NM_001040142.2:c.387-10G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001040142.2(SCN2A):​c.387-10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00362 in 1,586,860 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 12 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 107 hom. )

Consequence

SCN2A
NM_001040142.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.27

Publications

5 publications found
Variant links:
Genes affected
SCN2A (HGNC:10588): (sodium voltage-gated channel alpha subunit 2) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
SCN2A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • developmental and epileptic encephalopathy, 11
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • episodic ataxia, type 9
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • seizures, benign familial infantile, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign familial neonatal-infantile seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 2-165307838-G-A is Benign according to our data. Variant chr2-165307838-G-A is described in ClinVar as Benign. ClinVar VariationId is 130221.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0674 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001040142.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN2A
NM_001040142.2
MANE Select
c.387-10G>A
intron
N/ANP_001035232.1
SCN2A
NM_001371246.1
MANE Plus Clinical
c.387-10G>A
intron
N/ANP_001358175.1
SCN2A
NM_001040143.2
c.387-10G>A
intron
N/ANP_001035233.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN2A
ENST00000375437.7
TSL:5 MANE Select
c.387-10G>A
intron
N/AENSP00000364586.2
SCN2A
ENST00000631182.3
TSL:5 MANE Plus Clinical
c.387-10G>A
intron
N/AENSP00000486885.1
SCN2A
ENST00000283256.10
TSL:1
c.387-10G>A
intron
N/AENSP00000283256.6

Frequencies

GnomAD3 genomes
AF:
0.00382
AC:
581
AN:
152090
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000590
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.0738
Gnomad SAS
AF:
0.00643
Gnomad FIN
AF:
0.00321
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00100
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00730
AC:
1834
AN:
251174
AF XY:
0.00696
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00745
Gnomad EAS exome
AF:
0.0739
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.00142
Gnomad OTH exome
AF:
0.00376
GnomAD4 exome
AF:
0.00360
AC:
5170
AN:
1434654
Hom.:
107
Cov.:
27
AF XY:
0.00371
AC XY:
2655
AN XY:
715592
show subpopulations
African (AFR)
AF:
0.000183
AC:
6
AN:
32868
American (AMR)
AF:
0.000246
AC:
11
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.00782
AC:
203
AN:
25960
East Asian (EAS)
AF:
0.0746
AC:
2944
AN:
39456
South Asian (SAS)
AF:
0.00428
AC:
367
AN:
85656
European-Finnish (FIN)
AF:
0.00272
AC:
145
AN:
53368
Middle Eastern (MID)
AF:
0.00210
AC:
12
AN:
5714
European-Non Finnish (NFE)
AF:
0.00113
AC:
1229
AN:
1087508
Other (OTH)
AF:
0.00426
AC:
253
AN:
59438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
245
490
734
979
1224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00380
AC:
578
AN:
152206
Hom.:
12
Cov.:
32
AF XY:
0.00460
AC XY:
342
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41556
American (AMR)
AF:
0.000589
AC:
9
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3470
East Asian (EAS)
AF:
0.0734
AC:
381
AN:
5188
South Asian (SAS)
AF:
0.00644
AC:
31
AN:
4816
European-Finnish (FIN)
AF:
0.00321
AC:
34
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00100
AC:
68
AN:
67972
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00168
Hom.:
1
Bravo
AF:
0.00437
Asia WGS
AF:
0.0350
AC:
120
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
not provided (2)
-
-
1
Seizures, benign familial infantile, 3 (1)
-
-
1
Seizures, benign familial infantile, 3;C3150987:Developmental and epileptic encephalopathy, 11 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.18
DANN
Benign
0.74
PhyloP100
-1.3
PromoterAI
-0.0043
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2304015; hg19: chr2-166164348; COSMIC: COSV51848205; COSMIC: COSV51848205; API